相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Formulation and preclinical evaluation of 99mTc-gemcitabine as a novel radiopharmaceutical for solid tumor imaging
A. B. Ibrahim et al.
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2014)
Transdermal drug delivery of paroxetine through lipid- vesicular formulation to augment its bioavailability
Mohamed A. El-Nabarawi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Synthesis and pharmacological evaluation of 99mTc-labeled imidazolyl-containing diphosphonic acid as a novel bone imaging agent
Ling Qiu et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2013)
Biodistribution of 99mTc-sunitinib as a potential radiotracer for tumor hypoxia imaging
T. M. Sakr et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2013)
99mTc-labeled butyl-substituted zoledronic acid as a novel potential SPECT imaging agent: preparation and preclinical pharmacology study
Ling Qiu et al.
MEDICINAL CHEMISTRY RESEARCH (2013)
Preparation and in vivo biological investigation of 99mTc-HEIDP as a novel radioligand for bone scanning
Ling Qiu et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2012)
Preparation and bioevaluation of 99mTc nitrido radiopharmaceuticals with pyrazolo[1,5-a]pyrimidine as tumor imaging agents
Rui Ding et al.
MEDICINAL CHEMISTRY RESEARCH (2012)
Preliminary studies of 99mTc-memantine derivatives for NMDA receptor imaging
Xingqin Zhou et al.
NUCLEAR MEDICINE AND BIOLOGY (2012)
Animal studies of 99mTc-i-PIDP: A new bone imaging agent
Yan Wang et al.
APPLIED RADIATION AND ISOTOPES (2011)
Synthesis and Biological Evaluation of Novel 99mTc-Labelled Bisphosphonates as Superior Bone Imaging Agents
Ling Qiu et al.
MOLECULES (2011)
Preparation and in vivo biological investigations on a novel radioligand for bone scanning: technetium-99m-labeled zoledronic acid derivative
Jianguo Lin et al.
NUCLEAR MEDICINE AND BIOLOGY (2011)
Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
David E. Hughes et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Bisphosphonates: Mechanism of action and role in clinical practice
Mathew T. Drake et al.
MAYO CLINIC PROCEEDINGS (2008)
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
R. G. G. Russell et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women
Irene Lambrinoudaki et al.
CLINICAL INTERVENTIONS IN AGING (2008)
Preparation and biodistribution of 99mTc-lomefloxacin and 99mTc-ofloxacin complexes
M. A. Motaleb
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2007)
Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide
AS Guinedi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Recommendations for zoledronic acid treatment of patients with bone metastases
JR Berenson
ONCOLOGIST (2005)